Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21
Published February 10, 2016 · Recall initiated: January 28, 2016
Summary
FDA records drug Class III recall D-0650-2016, published February 10, 2016 and initiated January 28, 2016. Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories); Status: Terminated; Reported quantity: 868 unit cartons (86,800 tablets); Lot: Lot # 3063759, Exp.07/16. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- Distributor
- Nationwide
- Lot
- Lot # 3063759, Exp.07/16
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cardsMay 18, 2022
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10 cardsMay 18, 2022
- FDADiltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each perAugust 29, 2018
- FDALoxapine Capsules, USP 50 mg, packaged in 100 Unit Dose capsules, Rx only, Manufactured by MylanMay 30, 2018
- FDALyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of PfizerFebruary 10, 2016
- FDANystatin, USP Powder for Rx compounding, 50 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDCFebruary 10, 2016
Questions about this recall
Was Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21 recalled?
Yes. FDA published recall D-0650-2016 on February 10, 2016. Reported hazard: Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.
What should I do if I have this product?
Voluntary: Firm initiated · Letter